Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Proefschrift: Verbeteren van testen op hiv in Kenia
jan 2022 | HIV, Virale infecties